|
Ensemble Discovery’s intellectual property estate includes patents
and trade secrets. Our patent estate includes the patent families that
Ensemble exclusively licensed from Harvard University that include the
DNA-Programmed Chemistry™ (DPC™) platform technology invented in Professor
David Liu’s lab at Harvard.
Our patent estate also includes numerous patent applications filed
by Ensemble that protect our inventions directed at various improvements
and applications of the DPC technology in the discovery and development
of novel therapeutic and diagnostic agents.
The US and European patent offices have issued three patents that
are related to our core DPC technology.
Issued or Granted
- US Patent No. 7,070,928 B1 PDF (5.9 MB)
US 7,070,928 includes 71 claims and
broadly relates to methods for performing synthesis using nucleic acid-templated
reactions.
- US Patent No. 7,223,545 B1 PDF (5.7 MB)
US 7,223,545 includes 12 claims and
is related to methods for making compounds from small molecule scaffolds
and decorating them with various building blocks by nucleic acid-templated
reactions.
- European Patent No. 1,423,400 B1 PDF (1.6 MB)
EP 1,423,400 B1 includes 67
claims and broadly relates to methods for performing synthesis using
nucleic acid-templated reactions.
[ ]
|
